Blue Owl Capital Inc. is leading a private credit transaction of roughly $4 billion for PCI Pharma Services, according to people with knowledge of the matter, in what would be one of the largest direct lending deals of the year.
To read the entire story, you must be logged in.
Please log in now or register with us.
